BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 26488091)

  • 1. [High-risk medical devices: Variable evidence after approval].
    Zens Y
    Dtsch Med Wochenschr; 2015 Oct; 140(21):1574. PubMed ID: 26488091
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmaceuticals and medical devices: medical devices. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2010 Jan; ():1-25. PubMed ID: 20217916
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmaceuticals and Medical Devices: Medical Devices.
    Berry MD;
    Issue Brief Health Policy Track Serv; 2015 Dec; ():1-64. PubMed ID: 27116798
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluating sex differences in medical device clinical trials: time for action.
    Dhruva SS; Redberg RF
    JAMA; 2012 Mar; 307(11):1145-6. PubMed ID: 22378695
    [No Abstract]   [Full Text] [Related]  

  • 5. Characteristics of Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving FDA Premarket Approval in 2010 and 2011.
    Rathi VK; Krumholz HM; Masoudi FA; Ross JS
    JAMA; 2015 Aug; 314(6):604-12. PubMed ID: 26262798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical devices: problems on the rise.
    Consum Rep; 2007 Dec; 72(12):53. PubMed ID: 18038480
    [No Abstract]   [Full Text] [Related]  

  • 7. Ensuring safe and effective medical devices.
    Feigal DW; Gardner SN; McClellan M
    N Engl J Med; 2003 Jan; 348(3):191-2. PubMed ID: 12529457
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical research and the development of new devices: considerations for nurses.
    Lanter J
    Dimens Crit Care Nurs; 2007; 26(3):117-20. PubMed ID: 17440296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IOM tells FDA to develop new regulatory pathway for medical devices.
    Thompson CA
    Am J Health Syst Pharm; 2011 Sep; 68(18):1672. PubMed ID: 21880875
    [No Abstract]   [Full Text] [Related]  

  • 10. Medical devices; medical device user facility and manufacturer reporting, certification and registration; Office of Management and Budget approval; extension of effective date--FDA. Final rule; notification of approval of information collection requirements.
    Fed Regist; 1996 Apr; 61(71):16043-5. PubMed ID: 10157704
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence strength in FDA premarket approval of cardiovascular devices.
    Kong DF; Hasselblad V; Krucoff MW
    JAMA; 2010 Apr; 303(16):1599-600; author reply 1600-1. PubMed ID: 20424248
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA "approval" of medical devices.
    Health Devices; 1999; 28(5-6):235. PubMed ID: 10412079
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmaceuticals and Medical Devices: FDA Oversight.
    White RS;
    Issue Brief Health Policy Track Serv; 2018 Dec; 2018():1-42. PubMed ID: 30695853
    [No Abstract]   [Full Text] [Related]  

  • 14. The Central and Unacknowledged Role of the US Food and Drug Administration in the Design and Execution of Medical Device Pivotal Trials.
    Kaplan AV; Stern AD
    JAMA Cardiol; 2018 Jan; 3(1):5-6. PubMed ID: 29094158
    [No Abstract]   [Full Text] [Related]  

  • 15. When to conduct a clinical trial.
    Boutrand JP
    Med Device Technol; 2004 Oct; 15(8):28-31. PubMed ID: 16225271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceuticals and medical devices: medical devices. Issue brief.
    Health Policy Tracking Service, A Service of Thomson Reuters/West
    Issue Brief Health Policy Track Serv; 2011 Jan; ():1-24. PubMed ID: 21374838
    [No Abstract]   [Full Text] [Related]  

  • 17. Modernizing device regulation.
    Garber AM
    N Engl J Med; 2010 Apr; 362(13):1161-3. PubMed ID: 20335575
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmaceuticals and Medical Devices: FDA Oversight.
    Berry MD; White RS;
    Issue Brief Health Policy Track Serv; 2016 Dec; 2016():1-59. PubMed ID: 28252888
    [No Abstract]   [Full Text] [Related]  

  • 19. Transparency and Dermatologic Device Approval by the US Food and Drug Administration.
    Ezaldein HH; Scott JF; Yin ES; Ventura A; DeRuyter NP; Leffell DJ
    JAMA Dermatol; 2018 Mar; 154(3):273-280. PubMed ID: 29365020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. More safety data sought for high-risk devices.
    Voelker R
    JAMA; 2009 May; 301(18):1867. PubMed ID: 19436007
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.